Table 3
Two-, five- and ten-year age-standardized cancer prevalence proportion trends, by cancer type, Canada excluding Quebec, 1994 to 2008
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Cancer type | Two-year (1994 to 2008) | Five-year (1997 to 2008) | Ten-year (2002 to 2008) | ||
---|---|---|---|---|---|
APC / Trend change year / APC | AAPC | APC / Trend change year / APC | AAPC | APC | |
All cancers | -0.9 / 1997 / 0.8Note** | 0.4Note* | 1.0Note** | ... | 1.2Note** |
Oral cavity and pharynx | -3.3Note** / 1999 / -0.6* | -1.5Note* | -3.0Note** / 2000 / -0.6Note** | -1.3Note* | -0.6Note* |
Esophagus | 0.7Note** | ... | 1.0Note** | ... | 1.7Note** |
Stomach | -1.1Note** | ... | -1.2Note** / 2004 / 0.4 | -0.7Note* | -0.2 |
Colorectal | 0.4Note** | ... | 1.2Note** / 2003 / 0.4* | 0.9Note* | 0.9Note** |
Colon excluding rectum | 0.2 | ... | 1.0Note** / 2002 / 0.2 | 0.6Note* | 0.5Note** |
Rectum and rectosigmoid | 0.9Note** | ... | 1.9Note** / 2005 / 0.4 | 1.5Note* | 1.5Note** |
Anus | 5.1Note** / 2001 / -0.7 | 2.2Note* | 4.9Note** / 2002 / 0.2 | 2.3Note* | 1.6Note** |
Liver | 6.2Note** | ... | 6.7Note** | ... | 6.7Note** |
Pancreas | 1.8Note** | ... | 2.2Note** | ... | 2.5Note** |
Larynx | -3.2Note** | ... | -3.3Note** | ... | -3.2Note** |
Lung and bronchus | -0.6Note** / 2004 / 0.9 | -0.2 | -0.4Note** / 2005 / 1.0Note** | 0.0 | 0.2 |
Soft tissue | 1.0Note** / 2004 / 5.7Note** | 2.3Note* | 1.3Note** / 2005 / 5.1Note** | 2.3Note* | 2.9Note** |
Skin melanoma | 1.6Note** | ... | 2.1Note** / 2000 / 1.5Note** | 1.6Note* | 1.5Note** |
Breast | 0.4 / 2000 / -0.8Note** | -0.3 | 0.9Note** / 2001 / -0.7Note** | -0.1 | 0.0 |
Cervix uteriNote† | -1.9Note** | ... | -1.8Note** | ... | -1.6Note** |
Corpus uteriNote† | -1.7 / 1996 / 0.7Note** | 0.4 | 0.5Note** / 2006 / 1.3* | 0.7Note* | 0.7Note** |
OvaryNote† | -1.4* / 1998 / 0.4Note** | -0.1 | -0.3 / 2001 / 1.1Note** | 0.6Note* | 0.7Note** |
ProstateNote† | 0.5 | ... | 1.3Note** | ... | 1.5Note** |
TestisNote† | 1.1Note** | ... | 1.2Note** | ... | 1.2Note** |
Bladder (including in situ) | -0.9Note** | ... | -1.1Note** | ... | -1.1Note** |
Kidney and renal pelvis | 0.9Note** / 2006 / 6.3* | 1.7Note* | 1.3Note** / 2006 / 3.1* | 1.6Note* | 1.7Note** |
Brain | 0.4Note** | ... | 0.2 | ... | 0.2Note* |
Thyroid | 3.4* / 1999 / 8.7Note** | 6.7Note* | 3.1 / 2000 / 8.8Note** | 7.2Note* | 7.7Note** |
Hodgkin lymphoma | 0.0 | ... | 0.0 | ... | 0.1 |
Non-Hodgkin lymphoma | 1.6Note** | ... | 2.0Note** | ... | 2.5Note** |
Multiple myeloma | 1.3Note** | ... | 2.1Note** | ... | 2.4Note** |
Leukemias | 0.9* / 2002 / 2.7Note** | 1.7Note* | 1.1Note** / 2002 / 3.0Note** | 2.2Note* | 2.9Note** |
APC = annual percent change; AAPC = average annual percent change; when no change in trend is detected, the APC and AAPC are identical † sex-specific population data used to derive prevalence proportions underlying trend analysis * statistically significant (p < 0.05) ** statistically significant (p < 0.01) (applicable only for APC) ... not applicable Source: Canadian Cancer Registry—Statistics Canada and provincial/territorial cancer registries. |
- Date modified: